Eosinophilic peritonitis and nephrotic syndrome in Kimura’s disease: a case report and literature review

BMC Nephrology

Table 1 Time-course changes in 24-h proteinuria, serum albumin, serum creatinine, Kt/V, Ccr and lymph node size of bilateral inguinal regions according to prednisolone therapy

	admission	0	15 days	45 days	75 days	135 days
Prednisolone dosage, mg/d	/	30	30	30	25	25
24-h proteinuria, g/d	13.9	5.8	6.1	2.3	3.4	2.4
Serum albumin, g/l	18	18	19	31	35.9	39.3
Serum creatinine, umol/l	829	559	528	344	367	354
Peritoneal dialysis dosage, ml/d	0	4500	3000	3000	1500	1500
Kt/V renal	/	/	1.29	2.77	2.10	4.25
Kt/V peritoneal	/	/	0.51	0.75	0.29	0.34
Ccr renal, l/week per 1.73 m²	/	/	24.69	51.83	39.54	81.92
Ccr peritoneal, l/week per 1.73 m²	/	/	0.51	0.83	0.35	9.49
Left maximal long axes (mm)	/	21	26	19	16	20
Left maximal short axes (mm)	/	8	9	6	5	5
Right maximal long axes (mm)	/	24	27	24	20	24
Right maximal short axes (mm)	/	7	8	5	5	7

Kt/V renal was estimated via the concurrent 24-h urine urea excretion. Kt/V Peritoneal was estimated via 24-h dialysate urea excretion and the serum urea concentration. Ccr. creatinine clearance rate; Ccr peritoneal was estimated from the 24-h dialysate creatinine excretion and the serum creatinine concentration at the completion of the collection. Ccr renal was estimated as the average of renal creatinine and urea clearance (Ccr + Curea)/2
Note: prednisone was tapered to 25 mg/d at 60 d. Peritoneal dialysis dosage decreased from 4500 ml/d to 3000 ml/d at 10 d; peritoneal dialysis dosage decreased from 3000 ml/d to 1500 ml/d at 60 d;

ISSN: 1471-2369